Appili Therapeutics Inc. (TSX:APLI)
Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
Aug 10, 2026, 9:08 AM EST

Appili Therapeutics Financials Overview

Millions CAD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
0.240.240.10.830.331.39
Revenue Growth
143.10%143.10%-87.86%147.59%-75.97%-
Gross Profit
0.240.240.10.830.331.39
Operating Income
-9.23-9.23-19.98-13.94-8.05-25.74
Net Income
-4.24-4.24-2.62-3.78-9.24-25.12
Earnings Per Share
-0.03-0.03-0.02-0.03-0.08-0.38
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.040.041.230.092.476.66
Total Debt
12.9412.9412.298.187.674.98
Net Cash (Debt)
-12.9-12.9-11.07-8.09-5.21.69
Net Cash Growth
------88.83%
Net Cash Per Share
-0.10-0.10-0.09-0.07-0.050.03

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-1.34-1.340.87-2.46-10.1-19.08
Capital Expenditures
---0-0.03-0-
Free Cash Flow
-1.34-1.340.87-2.49-10.1-19.08
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-3779.42%-3779.42%-19891.20%-1684.49%-2409.73%-1851.00%
Pretax Margin
-4082.66%-4082.66%-21640.13%-1887.52%-2619.67%-1964.47%
Profit Margin
-4125.81%-4125.81%-21658.90%-1895.93%-2630.56%-1967.23%
FCF Margin
-547.72%-547.72%862.63%-301.44%-3022.65%-1372.07%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-3.483.483.483.483.48
P/FCF Ratio
--4.90---
PS Ratio
5.427.6042.265.1314.526.15